These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21314931)

  • 1. β-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up.
    De Santis M; Inzitari R; Bosello SL; Peluso G; Fanali C; Iavarone F; Zizzo G; Bocci M; Cabras T; Messana I; Fuso L; Varone F; Pagliari G; Castagnola M; Ferraccioli G
    Respir Res; 2011 Feb; 12(1):22. PubMed ID: 21314931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
    Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
    Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.
    Strange C; Bolster MB; Roth MD; Silver RM; Theodore A; Goldin J; Clements P; Chung J; Elashoff RM; Suh R; Smith EA; Furst DE; Tashkin DP;
    Am J Respir Crit Care Med; 2008 Jan; 177(1):91-8. PubMed ID: 17901414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vascular endothelial growth factor deficiency characterises scleroderma lung disease.
    De Santis M; Bosello SL; Capoluongo E; Inzitari R; Peluso G; Lulli P; Zizzo G; Bocci M; Tolusso B; Zuppi C; Castagnola M; Ferraccioli G
    Ann Rheum Dis; 2012 Sep; 71(9):1461-5. PubMed ID: 22402140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
    Salaffi F; Carotti M; Baldelli S; Bichi Secchi E; Manganelli P; Subiaco S; Salvolini L
    Radiol Med; 1999; 97(1-2):33-41. PubMed ID: 10319097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I is partially responsible for fibroblast proliferation induced by bronchoalveolar lavage fluid from patients with systemic sclerosis.
    Harrison NK; Cambrey AD; Myers AR; Southcott AM; Black CM; du Bois RM; Laurent GJ; McAnulty RJ
    Clin Sci (Lond); 1994 Feb; 86(2):141-8. PubMed ID: 8143424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease.
    De Santis M; Bosello SL; Peluso G; Pinnelli M; Alivernini S; Zizzo G; Bocci M; Capacci A; La Torre G; Mannocci A; Pagliari G; Varone F; Pistelli R; Danza FM; Ferraccioli G
    Clin Respir J; 2012 Jan; 6(1):9-17. PubMed ID: 21801327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal truncation of thymosin beta10 by an intracellular protease and its influence on the interaction with G-actin studied by ultrafiltration.
    Huff T; Müller CS; Hannappel E
    FEBS Lett; 1997 Sep; 414(1):39-44. PubMed ID: 9305728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
    Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis.
    Richard M; Cox D; Earle L; Varga J
    Clin Nucl Med; 1998 Jan; 23(1):19-25. PubMed ID: 9442960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin β
    Faa G; Messana I; Coni P; Piras M; Pichiri G; Piludu M; Iavarone F; Desiderio C; Vento G; Tirone C; Manconi B; Olianas A; Contini C; Cabras T; Castagnola M
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis.
    Sfriso P; Cozzi F; Oliviero F; Caso F; Cardarelli S; Facco M; Fittà C; Del Rosso A; Matucci-Cerinic M; Punzi L; Agostini C
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S71-5. PubMed ID: 22691213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage.
    Silver RM; Metcalf JF; Stanley JH; LeRoy EC
    Arthritis Rheum; 1984 Nov; 27(11):1254-62. PubMed ID: 6497920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.
    Schmidt K; Martinez-Gamboa L; Meier S; Witt C; Meisel C; Hanitsch LG; Becker MO; Huscher D; Burmester GR; Riemekasten G
    Arthritis Res Ther; 2009; 11(4):R111. PubMed ID: 19615053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.
    Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
    Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis.
    Kowal-Bielecka O; Kowal K; Lewszuk A; Bodzenta-Lukaszyk A; Walecki J; Sierakowski S
    Ann Rheum Dis; 2005 Mar; 64(3):484-6. PubMed ID: 15708900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
    Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
    J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide versus placebo in scleroderma lung disease.
    Tashkin DP; Elashoff R; Clements PJ; Goldin J; Roth MD; Furst DE; Arriola E; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M;
    N Engl J Med; 2006 Jun; 354(25):2655-66. PubMed ID: 16790698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
    Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
    Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.